5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 27.95▲ | 27.95▲ | 27.95▲ | 28.35▲ | 28.02▲ |
MA10 | 27.64▲ | 27.55▲ | 27.55▲ | 28.08▲ | 27.46▲ |
MA20 | 26.33▲ | 25.83▲ | 25.83▲ | 28.02▲ | 26.16▲ |
MA50 | N/A | N/A | N/A | 27.34▲ | N/A |
MA100 | N/A | N/A | N/A | 26.02▲ | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 0.020▲ | N/A |
RSI | 66.735▲ | 65.640▲ | 65.640▲ | 69.412▲ | 67.171▲ |
STOCH | 97.475▲ | 98.195▲ | 98.195▲ | 18.716▼ | 74.960 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -69.391 | -36.141 |
CCI | 102.222▲ | 89.370 | 89.370 | 119.170▲ | 102.266▲ |
Thursday, July 17, 2025 06:31 AM
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) is a leading developer of autologous adult stem cell therapies for debilitating neurodegenerative diseases.
|
Tuesday, July 08, 2025 05:00 AM
NEW YORK, July 8, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today acknowledged that ...
|
Tuesday, July 01, 2025 09:08 AM
Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, buoyed by blockbuster initial public offerings of big names like CoreWeave and Chime and a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 28.569 | 28.613 | 28.569 | 28.613 | 300 |
07/08/25 | 28.5615 | 28.5615 | 28.5615 | 28.5615 | 23 |
06/08/25 | 28.39 | 28.40 | 28.29 | 28.37 | 1,355 |
05/08/25 | 28.22 | 28.22 | 28.18 | 28.202 | 1,600 |
04/08/25 | 27.93 | 28.00 | 27.93 | 27.99 | 1,500 |
01/08/25 | 27.688 | 27.785 | 27.688 | 27.785 | 1,249 |
31/07/25 | 27.8015 | 27.8015 | 27.762 | 27.762 | 751 |
30/07/25 | 30.71 | 30.71 | 27.7798 | 27.7798 | 4,020 |
29/07/25 | 27.97 | 27.98 | 27.9213 | 27.9213 | 3,393 |
28/07/25 | 27.90 | 27.90 | 27.8407 | 27.86 | 3,276 |
|
|
||||
|
|
||||
|
|